Rivastigmine-d3 hydrochloride | MedChemExpress (MCE)
Rivastigmine-d3 hydrochloride is deuterated labeled Rivastigmine (HY-17368). Rivastigmine (S-Rivastigmine) is an orally active and potent cholinesterase (ChE) inhibitor and inhibits butyrylcholinesterase (BChE) and acetylcholinesteras (AChE) with IC50s of 0.037 μM , 4.15 μM, respectively. Rivastigmine can pass the blood brain barrier (BBB). Rivastigmine is a parasympathomimetic or cholinergic agent used for the research of mild to moderate dementia of the Alzheimer’s type and dementia due to Parkinson’s disease[1][2].
| Trivial name | Rivastigmine-d3 hydrochloride |
| Catalog Number | HY-17368S2 |
| Alternative Name(s) | S-Rivastigmine-d3 hydrochloride |
| Research Area | Neurological Disease |
| Purity | ≥98.0% |
| SMILES | O=C(N(C)CC)OC1=CC=CC([C@H](C)N(C)C([2H])([2H])[2H])=C1.Cl |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/rivastigmine-d3-hydrochloride.html |